Cellebrite DI Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Cellebrite DI Ltd. covers the month of August 2025. The report serves to announce the scheduling of the Company's Annual General Meeting of Shareholders, which is set to take place on Friday, September 19, 2025, at 4:00 p.m. Israel time at the Company's principal executive office in Petah Tikva, Israel.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural notice regarding shareholder meetings and does not contain financial performance data.
Material Changes
No material changes to financial performance or operations are reported in this filing. The document focuses solely on corporate governance procedures related to the upcoming Annual General Meeting.
Guidance, Outlook, and Risks
The filing includes no management commentary on future guidance, outlook, risks, or contingencies. It details the inclusion of a Notice and Proxy Statement and a Proxy Card as exhibits, which describe voting proposals and procedures. The filing notes that the report and exhibits (excluding the CEO's letter) are incorporated by reference into specific registration statements on Forms S-8 and F-3.
Key Facts for Investor Verification
- Meeting Date: Annual General Meeting scheduled for September 19, 2025.
- Meeting Time: 4:00 p.m. Israel time.
- Location: 94 Shlomo Shmelzer Road, Petah Tikva 4970602, Israel.
- Voting Materials: Notice and Proxy Statement (Exhibit 99.1) and Proxy Card (Exhibit 99.2) are attached for shareholder review.
- Financial Data: No financial results are included in this specific filing; investors should refer to the Company's most recent Form 20-F or quarterly reports for financial metrics.